|Articles|September 1, 2012
- Pharmaceutical Executive-09-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2012
Busting the Tape
Advertisement
Articles in this issue
over 13 years ago
Pharm Exec's 11th Annual Industry Auditover 13 years ago
Patients Wade Into the Pricing Debateover 13 years ago
The Endless Treadmill of End-of-Life Careover 13 years ago
The Power of Patient Feedbackover 13 years ago
The Payer C Change: From Customers to Competitorsover 13 years ago
The Margin Callover 13 years ago
Open Innovation in Pharma: Defining the DialogueAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5